 Official logo | |
| Company type | Public (SASE: BSNLR) |
|---|---|
| Industry | Pharmaceutical |
| Founded | 1951; 73 years ago (1951) |
| Headquarters | Sarajevo, Bosnia and Herzegovina |
| Key people | Adnan Hadžić (General director) |
| Products | Solid oral form medicines, ampule medicines, galenic products, non-pharmaceutical chemical products |
| Revenue |  €80.91 million (2018) |
| Net income | €6.62 million (2018) |
| Total assets | €157.01 million (2018) |
| Total equity | €91.00 million (2018) |
| Owner | Haden S.A. (25.95%) KBC Euro Credit Capital (23.68%) Economic and Social Development Fund (7.60%) Others |
| Number of employees | 720 (2019) |
| Website | http://www.bosnalijek.ba/ |
Bosnalijek is a Bosnian pharmaceutical company headquartered in Sarajevo, Bosnia and Herzegovina. Established in 1951, it is the largest pharmaceutical company in Bosnia and Herzegovina, present in more than 20 markets and having annual revenue of around 80 million euros (as of 2018).
History
Bosnalijek was established in 1951 in Sarajevo, FPR Yugoslavia, present-day Bosnia and Herzegovina.
In 2005, the International Finance Corporation provided Bosnalijek with a €7.5 million loan for the construction of an €18.5 million production and distribution center.
In August 2016, Bosnalijek celebrated its 65-year anniversary. In October 2016, the Government of the Federation of Bosnia and Herzegovina sold its remaining shares in the company in the auction.
As of 2019, Bosnalijek is presented in more than 20 markets, with revenues from foreign markets accounting for 76% of all revenues.
References
- ^ "Report on Company operations in 4th quarter 2018" (PDF). bosnalijek.com (in Bosnian). Retrieved 9 June 2019.
- "BOSNALIJEK D.D. SARAJEVO Opće informacije". sase.ba (in Bosnian). Retrieved 9 June 2019.
- Summary of Project Information, Project Number 24017, International Finance Corporation, World Bank Group. Accessed 2008-01-14.
- "Bosnalijek slavi 65 godina uspješnog rada". klix.ba (in Bosnian). 14 August 2016. Retrieved 9 June 2019.
- "Bosnia region sells stake in drugmaker Bosnalijek for $13.4 mln". reuters.com. 6 October 2016. Retrieved 9 June 2019.
- "Uzunović: Najveći dio prihoda od prodaje Bosnalijek realizira van BiH". biznis.ba (in Bosnian). 12 May 2019. Retrieved 9 June 2019.
External links
Media related to Bosnalijek at Wikimedia Commons
 | This European corporation or company article is a stub. You can help Misplaced Pages by expanding it. |